4.7 Article

ImprimatinC1, a novel plant immune-priming compound, functions as a partial agonist of salicylic acid

Journal

SCIENTIFIC REPORTS
Volume 2, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep00705

Keywords

-

Funding

  1. KAKENHI [19039034, 19678001, 24228008, 22780036]
  2. MEXT
  3. Sumitomo Foundation
  4. Kurata Memorial Hitachi Science and Technology Foundation
  5. Ryobi Teien Memory Foundation
  6. Grants-in-Aid for Scientific Research [19039034, 22780036] Funding Source: KAKEN

Ask authors/readers for more resources

Plant activators are agrochemicals that protect crops from pathogens. They confer durable resistance to a broad range of diseases by activating intrinsic immune mechanisms in plants. To obtain leads regarding useful compounds, we have screened a chemical library using an established method that allows selective identification of immune-priming compounds. Here, we report the characterisation of one of the isolated chemicals, imprimatinC1, and its structural derivative imprimatinC2. ImprimatinC1 functions as a weak analogue of salicylic acid (SA) and activates the expression of defence-related genes. However, it lacks antagonistic activity toward jasmonic acid. Structure-activity relationship analysis suggests that imprimatinC1 and C2 can be metabolised to 4-chlorobenzoic acid and 3,4-chlorobenzoic acid, respectively, to function in Arabidopsis. We also found that imprimatinC1 and C2 and their potential functional metabolites acted as partial agonists of SA. Thus, imprimatinC compounds could be useful tools for dissecting SA-dependent signal transduction pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available